Kloramfenikol Sandoz (Chloramphenicol)

Chloramphenicol interferes with bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation. This halts bacterial growth, allowing the body's immune defenses to clear the infection. The action is localized to the ocular surface when administered as eye drops.

The dosing regimen for Kloramfenikol Sandoz is determined by the prescribing clinician based on the type and severity of the eye infection, patient age and response to therapy. The prescriber will specify the number of drops, frequency and duration of treatment.

Chloramphenicol crosses the placenta and may be secreted in breast milk. Use during pregnancy or lactation is only recommended when the potential benefit outweighs the potential risk to the fetus or infant. The prescriber should evaluate the individual situation before prescribing.

To request Kloramfenikol Sandoz, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Chloramphenicol offers broad‑spectrum coverage against many Gram‑positive and some Gram‑negative ocular pathogens and is often used when resistance to fluoroquinolones is a concern. Compared with newer agents, it may have a lower risk of developing resistance but requires careful monitoring for rare systemic toxicity.

Kloramfenikol Sandoz should be stored below 25 °C in its original packaging, protected from moisture and direct light. Do not freeze the product. Ensure the container is tightly closed when not in use to maintain sterility and potency.

The product is applied topically to the affected eye(s) as directed by the prescriber. Typically, a few drops are placed in the conjunctival sac, avoiding contact with the eyelid or lashes. Patients should wash their hands before and after administration and follow any specific instructions regarding contact lens use.

Serious risks, though rare, include aplastic anemia, Stevens‑Johnson syndrome and toxic epidermal necrolysis, which are systemic hypersensitivity reactions. Immediate medical attention is required if patients experience unexplained fatigue, bruising, skin blistering or severe allergic symptoms while using the eye drops.

Patients with a known hypersensitivity to chloramphenicol or other amphenicol antibiotics should avoid this product. It is also contraindicated in individuals with a history of severe bone‑marrow suppression or those who have experienced serious allergic reactions to topical ophthalmic antibiotics.